Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates

Cites (295)

Items 201–289 of 289

1. Rate-Limiting Steps in Hepatic Drug Clearance: Comparison of Hepatocellular Uptake and Metabolism with Microsomal Metabolism of Saquinavir, Nelfinavir, and Ritonavir
   Alison J. Parker, James Brian. Houston · 2008 · Drug Metabolism and Disposition
2. Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans
   Cheng Li, Tongtong Liu, Xiaoming Cui, Annette Schettino Uss, K.-C. Cheng · 2007 · SLAS DISCOVERY
3. Pharmacokinetics and Metabolism in Drug Design
   Dennis A. Smith, H. Van De Waterbeemd, Don K. Walker · 2006 · Methods and principles in medicinal chemistry
4. ISATX247: a novel calcineurin inhibitor
   Launa J. Aspeslet, Derrick G. Freitag, Daniel J. Trepanier, M Abel, Selvaraj S. Naicker, Norman N. Kneteman, Robert T. Foster, Randall W. Yatscoff · 2001 · Transplantation Proceedings
5. Methods for the synthesis of macrocycle libraries for drug discovery
   Nicholas Kenneth Terrett · 2010 · Drug Discovery Today Technologies
6. Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes
   Ryan M. Franke, Sharyn D. Baker, Ron H.J. Mathijssen, EG Schuetz, Alex Sparreboom · 2008 · Clinical Pharmacology & Therapeutics
7. β-Hairpin protein epitope mimetic technology in drug discovery
   Daniel Obrecht, Éric Chevalier, Kerstin Moehle, John A. Robinson · 2011 · Drug Discovery Today Technologies
8. Analogue‐Based Drug Discovery II
   2010 · Wiley eBooks
9. Atazanavir/ritonavir: A review of its use in HIV therapy
   Nils von Hentig · 2008 · Drugs of today
10. Comparison of diffusion coefficients for matched pairs of macrocyclic and linear molecules over a drug-like molecular weight range
    Andrew R. Bogdan, Nichola L. Davies, Keith James · 2011 · Organic & Biomolecular Chemistry
11. Balancing novelty with confined chemical space in modern drug discovery
    José L. Medina‐Franco, Karina Martínez‐Mayorga, Nathalie Meurice · 2013 · Expert Opinion on Drug Discovery
12. Comprehensive Study on Structure−Activity Relationships of Rifamycins: Discussion of Molecular and Crystal Structure and Spectroscopic and Thermochemical Properties of Rifamycin O
    Alessia Bacchi, Giancarlo Pelizzi, Marino Nebuloni, P. Ferrari · 1998 · Journal of Medicinal Chemistry
13. Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays
    Vesna Munić Kos, Željko Kelnerić, Lara Mikac, Vesna Eraković Haber · 2010 · European Journal of Pharmaceutical Sciences
14. A Sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond
    Cele Abad‐Zapatero · 2007 · Drug Discovery Today
15. The X-ray analysis of the structure of rifamycin B
    Martina Brufani, WALTER FEDELI, Giordano Giacomello, ALESSANDRO VACIAGO · 1964 · Cellular and Molecular Life Sciences
16. Azithromycin effectiveness against intracellular infections of Francisella
    Saira Ahmad, Lyman Hunter, Aiping Qin, Barbara J. Mann, Monique L. van Hoek · 2010 · BMC Microbiology
17. Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) mice
    Richard H. Stephens, Catherine A. O’Neill, Joanne Bennett, Michael Humphrey, B Henry, Malcolm Rowland, Geoff Warhurst · 2002 · British Journal of Pharmacology
18. Comparison of ABC Transporter Modulation by Atazanavir in Lymphocytes and Human Brain Endothelial Cells: ABC Transporters Are Involved in the Atazanavir-Limited Passage across an in Vitro Human Model of the Blood–Brain Barrier
    Laurence Bousquet, Camille Roucairol, Alexandra Hembury, Marie‐Claire Nevers, Christophe Créminon, Robert Farinotti, Aloïse M Mabondzo · 2008 · AIDS Research and Human Retroviruses
19. Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model.
    Jean I. Pachot, Roger P. Botham, Klaus D. Haegele, Kin‐Kai Hwang · 2003 · PubMed
20. Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies
    Lan Gao, Jing Li, Claudia Kasserra, Qi Song, Ali Arjomand, David Hesk, Swapan K. Chowdhury · 2011 · Analytical Chemistry
21. Modulation of Digoxin Transport Across Caco-2 Cell Monolayers by Citrus Fruit Juices: Lime, Lemon, Grapefruit, and Pummelo
    Jianguo Xu, Mei‐Lin Go, Lee Yong Lim · 2003 · Pharmaceutical Research
22. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy?
    M. Gary Nicholls, Lynley K. Lewis, Timothy G. Yandle, Gwyn A. Lord, William McKinnon, Philip J. Hilton · 2008 · Journal of Hypertension
23. Update on alisporivir in treatment of viral hepatitis C
    Robert Flisiak, Jerzy Jaroszewicz, Iwona Flisiak, Tadeusz Wojciech Łapiński · 2012 · Expert Opinion on Investigational Drugs
24. In silicoprediction of substrate properties for ABC-multidrug transporters
    Michael Demel, Rita Schwaha, O Krämer, P Ettmayer, Eric E. J. Haaksma, Gerhard Franz Ecker · 2008 · Expert Opinion on Drug Metabolism & Toxicology
25. Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV
    E. Randall Lanier, Roger G. Ptak, Bernhard M. Lampert, Laurie Keilholz, Tracy L. Hartman, Robert W. Buckheit, Marie K. Mankowski, Mark C. Osterling, Merrick R. Almond, George R. Painter · 2010 · Antimicrobial Agents and Chemotherapy
26. Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
    X. Christopher Sheng, Todd C. Appleby, Thomas Butler, Ruby Z. Cai, Xiaowu Chen, Aesop Cho, Michael O. Clarke, Jeromy J. Cottell, William E. Delaney, Edward M. Doerffler et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
27. Interaction of Macrolide Antibiotics with Intestinally Expressed Human and Rat Organic Anion-Transporting Polypeptides
    Tian Lan, Anuradha Rao, Jamie Haywood, Charles B. Davis, Chao Han, Eric M. Garver, Paul A. Dawson · 2009 · Drug Metabolism and Disposition
28. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.
    Gordon A. Ellard, Petrus Bernard Fourie · 1999 · PubMed
29. Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound
    Wieslaw M. Kazmierski, Andrew T. Maynard, Maosheng Duan, Sam Baskaran, Janos Botyanszki, Renae M. Crosby, Scott H. Dickerson, Matthew D. Tallant, R.M. Grimes, Robert K. Hamatake et al. · 2014 · Journal of Medicinal Chemistry
30. The X-ray analysis of the structure of rifamycin Y
    Martina Brufani, WALTER FEDELI, Giordano Giacomello, ALESSANDRO VACIAGO · 1967 · Cellular and Molecular Life Sciences
31. Human Immunodeficiency Virus Protease Inhibitors Interact with ATP Binding Cassette Transporter 4/Multidrug Resistance Protein 4: A Basis for Unanticipated Enhanced Cytotoxicity
    Yu Fukuda, Kazumasa Takenaka, Alex Sparreboom, Satish Cheepala, Chung‐Pu Wu, Sean Ekins, Suresh V. Ambudkar, John D. Schuetz · 2013 · Molecular Pharmacology
32. Auranofin versus injectable gold
    Kenneth L. N. Blocka · 1983 · The American Journal of Medicine
33. Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay
    Hao Jiang, Jianing Zeng, Wenying Li, Marc Bifano, Huidong Gu, Craig Titsch, John A. Easter, Richard C. Burrell, Hamza Kandoussi, Anne‐Françoise Aubry et al. · 2012 · Analytical Chemistry
34. Involvement of Intestinal Uptake Transporters in the Absorption of Azithromycin and Clarithromycin in the Rat
    Eric M. Garver, Erin D. Hugger, Shawn Patrick Shearn, Anuradha Rao, Paul A. Dawson, Charles B. Davis, Chao Han · 2008 · Drug Metabolism and Disposition
35. New taxanes in development
    Cristiano Ferlini, Daniela Gallo, Giovanni Scambia · 2008 · Expert Opinion on Investigational Drugs
36. Verification of a Designed Intramolecular Hydrogen Bond in a Drug Scaffold by Nuclear Magnetic Resonance Spectroscopy
    Ariane Jansma, Qiong Zhang, Bing Li, Qiang Ding, Tetsuo Uno, Badry D. Bursulaya, Yi Liu, Pascal Furet, Nathanael S. Gray, Bernhard H. Geierstanger · 2007 · Journal of Medicinal Chemistry
37. Cyclosporine
    Richard J. Ptachcinski, Gilbert J. Burckart, Raman Venkataramanan · 1985 · Annals of Pharmacotherapy
38. A General Model for Prediction of Caco‐2 Cell Permeability
    Anneli Nordqvist, Jonas E. Nilsson, Tuulikki Lindmark, Alf Eriksson, Per Garberg, Mats Kihlén · 2004 · QSAR & Combinatorial Science
39. hNK2 receptor antagonists. The use of intramolecular hydrogen bonding to increase solubility and membrane permeability
    Alessandro Ettorre, Piero D’Andrea, Sandro Mauro, Marina Porcelloni, Cristina Rossi, Maria Maddalena Altamura, Rose‐Marie Catalioto, Sandro Giuliani, Carlo Alberto Maggi, Daniela Fattori · 2011 · Bioorganic & Medicinal Chemistry Letters
40. Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters
    Nicolas Picard, Laure Levoir, Fabien Lamoureux, Sook Wah Yee, Kathleen M. Giacomini, Pierre Marquet · 2011 · Xenobiotica
41. Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans
    Sanjeev Kumar, Eugene Y. Tan, Georgy Hartmann, Zachary Biddle, Arthur J. Bergman, James Dru, Jonathan Z. Ho, Allen N. Jones, Steven J. Staskiewicz, Matthew P. Braun et al. · 2009 · Drug Metabolism and Disposition
42. Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans
    Kyoung‐Ah Kim, Hye‐Mi Lee, Hyun‐Jin Joo, In‐Bae Park, Ji Young Park · 2013 · The Journal of Clinical Pharmacology
43. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus
    Fabien Lamoureux, Nicolas Picard, Belkacem Boussera, François‐Ludovic Sauvage, Pierre Marquet · 2011 · Fundamental and Clinical Pharmacology
44. Steady‐state pharmacokinetics of once‐daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*
    AD Luber, R Brower, Dokyoon Kim, Randee Silverman, Charles A. Peloquin, Ian Frank · 2007 · HIV Medicine
45. Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451
    Huiling Yang, Margaret F. Robinson, Amoreena C. Corsa, Betty Peng, Guofeng Cheng, Tian Yang, Yujin Wang, Rowchanak Pakdaman, Marian Shen, Xiaoping Qi et al. · 2013 · Antimicrobial Agents and Chemotherapy
46. The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 1
    Thien Duc Tran, Florian Wakenhut, Chris Pickford, Stephen Michael Shaw, Mike Westby, Caroline Smith‐Burchnell, Lesa Watson, Michael Paradowski, Jared B. J. Milbank, Rebecca A. Brimage et al. · 2014 · ChemMedChem
47. Roles of P-Glycoprotein, Bcrp, and Mrp2 in Biliary Excretion of Spiramycin in Mice
    Xianbin Tian, Jun Li, Maciej J. Zamek‐Gliszczynski, Arlene S. Bridges, Peijin Zhang, Nita J. Patel, Thomas J. Raub, Gary M. Pollack, Kim L. R. Brouwer · 2007 · Antimicrobial Agents and Chemotherapy
48. Assessment of Macrolide Transport Using PAMPA, Caco-2 and MDCKII-hMDR1 Assays
    Danijela Nožinić, Astrid Milić, Lara Mikac, Jovica Ralić, Jasna Padovan, Roberto Antolović · 2010 · University of Zagreb University Computing Centre (SRCE)
49. Pharmacokinetics, Metabolism, and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Rats and Rhesus Monkeys
    Eugene Y. Tan, Georgy Hartmann, Qing Chen, António Pereira, Scott A. Bradley, George A. Doss, Andy Shiqiang Zhang, Jonathan Z. Ho, Matthew P. Braun, Dennis C. Dean et al. · 2009 · Drug Metabolism and Disposition
50. Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection.
    Koichi Watashi · 2010 · PubMed
51. Influence of Conformation and Intramolecular Hydrogen Bonding on the Acyl Glucuronidation and Biliary Excretion of Acetylenic Bis-Dipyrrinones Related to Bilirubin
    Antony F. McDonagh, David A. Lightner · 2007 · Journal of Medicinal Chemistry
52. Side effects with amiodarone therapy
    Romesh Shukla, Nigel I. Jowett, David R. Thompson, Jürgen Pohl · 1994 · Postgraduate Medical Journal
53. A new model of binding of rifampicin and its amino analogues as zwitterions to bacterial RNA polymerase
    Krystian Pyta, Piotr Przybylski, Katarzyna Klich, Joanna Stefańska · 2012 · Organic & Biomolecular Chemistry
54. Chemoinformatic Analysis of Biologically Active Macrocycles
    Wolfgang Brandt, V. Joachim Haupt, Ludger A. Wessjohann · 2010 · Current Topics in Medicinal Chemistry
55. Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs
    Kazunori Hosoe, T. Mae, Eisaku Konishi, Kenji Fujii, K Yamashita, T Yamane, Toshiro HIDAKA, Takehisa Ohashi · 1996 · Antimicrobial Agents and Chemotherapy
56. Montelukast Is a Potent and Durable Inhibitor of Multidrug Resistance Protein 2-Mediated Efflux of Taxol and Saquinavir
    Upal Basu Roy, Geetika Chakravarty, Kerstin Höner zu Bentrup, Debasis Mondal · 2009 · Biological and Pharmaceutical Bulletin
57. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans
    Marc Trellu, A. Filali‐Ansary, D. Françon, R. Adam, Philippe Lluel, Catherine Dubruc, Jean‐Paul Thénot · 2004 · Fundamental and Clinical Pharmacology
58. Acyl Substitution at the Ortho Position of Anilides Enhances Oral Bioavailability of Thiophene Sulfonamides: TBC3214, an ETA Selective Endothelin Antagonist
    Chengde Wu, E. Radford Decker, Natalie Blok, Jian Li, Andree R. Bourgoyne, Huong Bui, Karin M. Keller, Vippra Knowles, Wen Jess Li, Fiona D. Stavros et al. · 2001 · Journal of Medicinal Chemistry
59. Drugs in middle space
    Nick Terrett · 2013 · MedChemComm
60. New Treatment Approaches to Myasthenia Gravis
    C. W. H. Havard, V Fonseca · 1990 · Drugs
61. Effect of pH, mucin and bovine serum on rifampicin permeability through Caco‐2 cells
    José Eduardo Gonçalves, Mariane B. Fernandes, Chang Chiann, Marı́a Nella Gai, Jacqueline de Souza, Sı́lvia Storpirtis · 2012 · Biopharmaceutics & Drug Disposition
62. The synthesis of novel taxoids for oral administration
    Yunrong Jing, Wei Jie Zhou, Wan-liang Li, Linxiang Zhao, Yongfeng Wang · 2013 · Bioorganic & Medicinal Chemistry
63. Pharmacodynamics and Pharmacokinetics of Spiramycin and Their Clinical Significance
    Itzhak Brook · 1998 · Clinical Pharmacokinetics
64. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    AF Cohen, Ria Kroon, Rik C. Schoemaker, DD Breimer, A. Van Vliet‐Verbeek, HC Brandenburg · 1993 · British Journal of Clinical Pharmacology
65. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells
    Kohei Togami, Sumio Chono, Kazuhiro Morimoto · 2012 · Die Pharmazie
66. Melt Extrusion
    James C. DiNunzio, Feng Zhang, Charlie Martin, James W. McGinity · 2011 · AAPS advances in the pharmaceutical sciences series
67. Effects of Esomeprazole on the Pharmacokinetics of Atazanavir and Fosamprenavir in a Patient with Human Immunodeficiency Virus Infection
    Jennifer J. Kiser, Kenneth A. Lichtenstein, Peter L. Anderson, Courtney Vail Fletcher · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
68. Efficacy of Novel Rifamycin Derivatives against Rifamycin-Sensitive and -Resistant Staphylococcus aureus Isolates in Murine Models of Infection
    David M. Rothstein, Ronald Farquhar, Klari Sirokman, Karen L. Sondergaard, C.A. Hazlett, Angelia A. Doye, Judith K. Gwathmey, Steve Mullin, John van Duzer, Christopher K. Murphy · 2006 · Antimicrobial Agents and Chemotherapy
69. The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison.
    Bernd Terhaag, Frank Donath, Le Petit G, K Feller · 1986 · PubMed
70. The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 2
    Florian Wakenhut, Thien Duc Tran, Chris Pickford, Stephen Michael Shaw, Mike Westby, Caroline Smith‐Burchnell, Lesa Watson, Michael Paradowski, Jared B. J. Milbank, David Stonehouse et al. · 2014 · ChemMedChem
71. Determination of the solution conformation of rifamycin S and derivatives by nuclear magnetic resonance
    Martha L. Casey, HOWARD W. JUN. WHITLOCK · 1975 · Journal of the American Chemical Society
72. Investigating the barriers to bioavailability of macrolide antibiotics in the rat
    Jasna Padovan, Jovica Ralić, Vatroslav Letfus, Astrid Milić, Vlatka Bencetić Mihaljević · 2011 · European Journal of Drug Metabolism and Pharmacokinetics
73. Single‐dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers
    Pierre Sandouk, M. Bouvier d'Yvoire, Pierre Chrétien, J.P. Tillement, Jean‐Michel Scherrmann · 1994 · Biopharmaceutics & Drug Disposition
74. Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor
    Jianmin Duan, Chan‐Loi Yong, Michel Garneau, Ma’an Amad, Gordon T. Bolger, Josie De Marte, Hélène Montpetit, François Otis, Martin Jutras, Manon Rhéaume et al. · 2011 · Xenobiotica
75. Chemical Modification of Macrolides
    Toshiaki Sunazuka, SADAFUMI OMURA, Shigeo Iwasaki, Satoshi Ōmura · 2003 · Elsevier eBooks
76. Hepatitis C virus NS3 protease inhibitors: Large, flexible molecules of peptide origin show satisfactory permeability across Caco-2 cells
    Christel A. S. Bergström, Sara Bolin, Per Artursson, Robert Rönn, Anja Sandström · 2009 · European Journal of Pharmaceutical Sciences
77. Chris Lipinski
    Chris Lipinski · 2012 · Nature Reviews Drug Discovery
78. Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats
    Jolana Cermanová, Leoš Fuksa, Eva Doleželová, Milos Hroch, Otto Kučera, Gabriela Kolouchová, Petra Hirsova, Jana Maláková, František Štaud, Jiřina Martı́nková et al. · 2009 · Pharmacological Research
79. Comments on Mougey et al. (2009)
    Xiaoyan Chu, George Philip, Raymond Evers · 2011 · Pharmacogenetics and Genomics
80. Translational synthetic chemistry
    Sarathy Kesavan, Lisa A. Marcaurelle · 2013 · Nature Chemical Biology
81. Rapid Stimulating Effect of the Antiarrhythmic Agent Amiodarone on Absorption of Organic Anion Compounds
    Masahiro Segawa, Jiro Ogura, Satoru Seki, Shirou Itagaki, Natsuko Takahashi, Masaki Kobayashi, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki · 2012 · Drug Metabolism and Pharmacokinetics
82. Effect of macrolide antibiotics on uptake of digoxin into rat liver
    Suwako Ito, Risa Nasu, Masayuki Tsujimoto, 秀康 村上, Hisakazu Ohtani, Yasufumi Sawada · 2007 · Biopharmaceutics & Drug Disposition
83. Effect of dose on bioavailability of oral digoxin
    Hermann Rudolf Ochs, Günther Bodem, David J. Greenblatt · 1981 · European Journal of Clinical Pharmacology
84. Solution conformation of the disaccharide of avermectin B1a examined by nmr spectroscopy and nuclear overhauser enhancement restrained hard-sphere exo-anomeric effect calculation.
    András Neszmélyi, Daisy Machytka, ANDREA KMETY, Péter Sándor, Gabor Lukacs · 1989 · The Journal of Antibiotics
85. Pharmacodynamic effects of ouabain following single sublingual and intravenous doses in normal subjects
    Gustav Georg Belz, J. Matthews, Ursula Sauer, Heiko C. Stern, B Schneider · 1984 · European Journal of Clinical Pharmacology
86. Drug Metabolism and Pharmacokinetics Quick Guide
    Johannes H. Proost · 2012 · International Journal of Clinical Pharmacology and Therapeutics
87. The Pharmacological Profile of Auranofin, an Orally Active Gold Compound
    D. T. Walz, Michael J. DiMartino, Don E. Griswold · 1983 · Scandinavian Journal of Rheumatology
88. Rifamycins, Antibacterial Antibiotics and Their New Applications
    Enrico Selva, Giancarlo Lancini · 2010
89. Transporters
    Siamak Cyrus Khojasteh, Harvey Wong, Cornelis E. C. A. Hop · 2011 · Springer eBooks